Sierra Oncology, Inc. Common Stock
SRRA
SRRA was delisted on the 30th of June, 2022.
44 hedge funds and large institutions have $25.7M invested in Sierra Oncology, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 20 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
12% less funds holding
Funds holding: 50 → 44 (-6)
30% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 20
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
82% less capital invested
Capital invested by funds: $140M → $25.7M (-$115M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$2.95M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.81M |
| 3 |
MA
Minerva Advisors
Bala Cynwyd,
Pennsylvania
|
+$545K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$402K |
| 5 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$316K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$20.1M |
| 2 |
O
OrbiMed
New York
|
-$10.9M |
| 3 |
DM
Deerfield Management
New York
|
-$6.63M |
| 4 |
RIM
RS Investment Management
San Francisco,
California
|
-$6.61M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$5.4M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LOAMU
51
Lombard Odier Asset Management (USA)
New York
| – | -$336K | -1,247 | Closed |
|
|
NPF
52
Norris Perne & French
Grand Rapids,
Michigan
| – | -$318K | -1,181 | Closed |
|
53
Renaissance Technologies
New York
| – | -$305K | -1,133 | Closed |
|
54
Goldman Sachs
New York
| – | -$295K | -1,094 | Closed |
|
55
Swiss National Bank
Zurich,
Switzerland
| – | -$206K | -788 | Closed |
|
|
VEA
56
Virtus ETF Advisers
New York
| – | -$121K | -448 | Closed |
|
57
Bank of New York Mellon
New York
| – | -$115K | -428 | Closed |
|
|
CS
58
Credit Suisse
Zurich,
Switzerland
| – | -$99K | -371 | Closed |
|
59
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
| – | -$97K | -350 | Closed |
|
|
DCM
60
DAFNA Capital Management
Los Angeles,
California
| – | -$67K | -250 | Closed |
|
|
BIT
61
BlackRock Institutional Trust
San Francisco,
California
| – | -$45K | -166 | Closed |
|
62
JP Morgan Chase
New York
| – | -$28K | -103 | Closed |
|
|
BG
63
BlackRock Group
London,
United Kingdom
| – | -$21K | -79 | Closed |
|
64
Teacher Retirement System of Texas
Austin,
Texas
| – | -$15K | -56 | Closed |
|
SRRA Hedge Fund Activity: Q2 2016 in Review
44 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sierra Oncology, Inc. Common Stock (SRRA) for Q2 2016, worth a combined $25.7M — down 82% from $140M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of SRRA and 14 opened new positions — a net loss of 6 holders — while 10 trimmed existing stakes and 11 added.
The largest buyer was Pictet Asset Management (UK), adding an estimated $2.95M. The largest seller was Fidelity Investments, cutting an estimated $20.1M.
- 44 institutional investors held Sierra Oncology, Inc. Common Stock (SRRA) as of Q2 2016, down from 50 in Q1 2016.
- Funds reported $25.7M of Sierra Oncology, Inc. Common Stock stock for Q2 2016, down 82% quarter-over-quarter.
- 14 funds opened new Sierra Oncology, Inc. Common Stock positions in Q2 2016 and 20 closed out, a net change of -6 holders.
- The largest Sierra Oncology, Inc. Common Stock buyer in Q2 2016 was Pictet Asset Management (UK), an estimated $2.95M added.
- The largest Sierra Oncology, Inc. Common Stock seller in Q2 2016 was Fidelity Investments, an estimated $20.1M sold.
Based on aggregated 13F filings for Q2 2016.